Surrozen (SRZN) Competitors $8.90 -1.26 (-12.40%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends SRZN vs. OCAX, ANRO, AVTX, IFRX, CABA, VXRT, RANI, IPSC, DERM, and CDTXShould you be buying Surrozen stock or one of its competitors? The main competitors of Surrozen include OCA Acquisition (OCAX), Alto Neuroscience (ANRO), Avalo Therapeutics (AVTX), InflaRx (IFRX), Cabaletta Bio (CABA), Vaxart (VXRT), Rani Therapeutics (RANI), Century Therapeutics (IPSC), Journey Medical (DERM), and Cidara Therapeutics (CDTX). Surrozen vs. OCA Acquisition Alto Neuroscience Avalo Therapeutics InflaRx Cabaletta Bio Vaxart Rani Therapeutics Century Therapeutics Journey Medical Cidara Therapeutics OCA Acquisition (NASDAQ:OCAX) and Surrozen (NASDAQ:SRZN) are both small-cap unclassified companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, profitability, earnings, community ranking, media sentiment, risk, analyst recommendations, institutional ownership and dividends. Is OCAX or SRZN more profitable? OCA Acquisition's return on equity of 0.00% beat Surrozen's return on equity.Company Net Margins Return on Equity Return on Assets OCA AcquisitionN/A N/A -7.58% Surrozen N/A -120.51%-54.68% Does the media refer more to OCAX or SRZN? In the previous week, OCA Acquisition's average media sentiment score of 0.00 equaled Surrozen'saverage media sentiment score. Company Overall Sentiment OCA Acquisition Neutral Surrozen Neutral Does the MarketBeat Community prefer OCAX or SRZN? Surrozen received 3 more outperform votes than OCA Acquisition when rated by MarketBeat users. CompanyUnderperformOutperformOCA AcquisitionN/AN/ASurrozenOutperform Votes316.67%Underperform Votes1583.33% Do institutionals and insiders have more ownership in OCAX or SRZN? 38.2% of OCA Acquisition shares are held by institutional investors. Comparatively, 66.6% of Surrozen shares are held by institutional investors. 48.9% of OCA Acquisition shares are held by insiders. Comparatively, 43.5% of Surrozen shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Which has stronger earnings and valuation, OCAX or SRZN? OCA Acquisition has higher earnings, but lower revenue than Surrozen. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOCA AcquisitionN/AN/A-$2.48MN/AN/ASurrozen$10M2.89-$43.04MN/AN/A Which has more volatility and risk, OCAX or SRZN? OCA Acquisition has a beta of -0.01, indicating that its share price is 101% less volatile than the S&P 500. Comparatively, Surrozen has a beta of 0.91, indicating that its share price is 9% less volatile than the S&P 500. SummaryOCA Acquisition and Surrozen tied by winning 4 of the 8 factors compared between the two stocks. Ad Weiss RatingsTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.This could be his favorite coin. Get Surrozen News Delivered to You Automatically Sign up to receive the latest news and ratings for SRZN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SRZN vs. The Competition Export to ExcelMetricSurrozenBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$28.93M$2.94B$5.05B$8.87BDividend YieldN/A1.89%4.97%4.06%P/E RatioN/A21.3797.3414.18Price / Sales2.89382.101,218.4289.42Price / CashN/A160.1133.5132.79Price / Book0.484.195.805.12Net Income-$43.04M-$41.63M$119.07M$225.99M7 Day Performance-6.12%-4.73%-1.83%-1.32%1 Month Performance-5.12%-6.53%-3.64%0.60%1 Year Performance47.60%25.63%31.62%26.23% Surrozen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SRZNSurrozen1.9247 of 5 stars$8.90-12.4%N/A+25.6%$28.93M$10M0.0042Gap DownHigh Trading VolumeOCAXOCA AcquisitionN/A$11.30flatN/AN/A$76.12MN/A0.00147,000ANROAlto Neuroscience3.532 of 5 stars$4.27-4.7%$20.00+368.4%N/A$115.16M$210,000.000.00N/AAnalyst RevisionAVTXAvalo Therapeutics2.3623 of 5 stars$10.90-1.4%N/A-47.4%$113.30M$820,000.000.0040Positive NewsIFRXInflaRx3.0872 of 5 stars$2.04+6.3%$8.00+292.2%+34.2%$113.06M$70,000.000.0060Gap UpCABACabaletta Bio2.0246 of 5 stars$2.26-11.0%$27.30+1,108.0%-87.4%$110.47MN/A-1.0550Analyst ForecastHigh Trading VolumeVXRTVaxart2.1331 of 5 stars$0.61-1.6%$3.00+393.6%-22.1%$110M$7.38M-1.48109Analyst RevisionNews CoverageRANIRani Therapeutics3.1555 of 5 stars$2.05-0.5%$11.71+471.4%+2.5%$109.75M$2.72M0.00110Analyst ForecastIPSCCentury Therapeutics1.5719 of 5 stars$1.26-1.6%$11.60+820.6%-11.9%$108.84M$2.23M0.00170DERMJourney Medical3.2915 of 5 stars$5.23-2.2%$9.38+79.3%N/A$108.42M$79.18M-5.6990Analyst RevisionPositive NewsCDTXCidara Therapeutics4.1784 of 5 stars$15.12-3.3%$30.50+101.7%+0.9%$106.60M$63.90M-0.5990 Related Companies and Tools Related Companies OCAX Competitors ANRO Competitors AVTX Competitors IFRX Competitors CABA Competitors VXRT Competitors RANI Competitors IPSC Competitors DERM Competitors CDTX Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SRZN) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Surrozen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Surrozen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SRZN Stock Alerts